ZA956419B - Pharmaceutical compound - Google Patents

Pharmaceutical compound

Info

Publication number
ZA956419B
ZA956419B ZA956419A ZA956419A ZA956419B ZA 956419 B ZA956419 B ZA 956419B ZA 956419 A ZA956419 A ZA 956419A ZA 956419 A ZA956419 A ZA 956419A ZA 956419 B ZA956419 B ZA 956419B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical compound
pharmaceutical
compound
Prior art date
Application number
ZA956419A
Inventor
Richard Maurice Ladd
Bryan Edward Mobbs
Francis David Cheetham
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of ZA956419B publication Critical patent/ZA956419B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA956419A 1994-08-02 1995-08-01 Pharmaceutical compound ZA956419B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9415617A GB9415617D0 (en) 1994-08-02 1994-08-02 Pharmaceutical compound

Publications (1)

Publication Number Publication Date
ZA956419B true ZA956419B (en) 1996-02-02

Family

ID=10759297

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA956419A ZA956419B (en) 1994-08-02 1995-08-01 Pharmaceutical compound

Country Status (8)

Country Link
EP (1) EP0775122A1 (en)
JP (1) JP2696082B2 (en)
KR (1) KR970704706A (en)
AU (1) AU3182195A (en)
CA (1) CA2194567A1 (en)
GB (1) GB9415617D0 (en)
WO (1) WO1996004257A1 (en)
ZA (1) ZA956419B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI9600165A (en) * 1996-05-21 1997-12-31 Krka Tovarna Zdravil D D Novo Process for preparation of biological active derivative of 1,2,4- triazole and intermediates useful in this process

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE58738B1 (en) * 1984-09-05 1993-11-03 Ici Plc Antifungal azole compounds
JP2630877B2 (en) * 1990-08-24 1997-07-16 持田製薬株式会社 Optically active triazole derivatives and compositions
TW211006B (en) * 1990-08-24 1993-08-11 Mochida Pharm Co Ltd

Also Published As

Publication number Publication date
GB9415617D0 (en) 1994-09-21
AU3182195A (en) 1996-03-04
KR970704706A (en) 1997-09-06
WO1996004257A1 (en) 1996-02-15
JPH08183780A (en) 1996-07-16
JP2696082B2 (en) 1998-01-14
CA2194567A1 (en) 1996-02-15
EP0775122A1 (en) 1997-05-28

Similar Documents

Publication Publication Date Title
GB9402807D0 (en) Pharmaceutical compounds
ZA959921B (en) Pharmaceutical compounds
GB9410387D0 (en) Pharmaceutical compounds
GB9502861D0 (en) Pharmaceutical compounds
GB2286394B (en) Pharmaceutical compounds
GB9426224D0 (en) Pharmaceutical compounds
ZA957607B (en) Pharmaceutical compounds
GB9417102D0 (en) Pharmaceutical compounds
GB9426071D0 (en) Pharmaceutical compounds
GB9426080D0 (en) Pharmaceutical compounds
ZA951175B (en) Pharmaceutical compounds
ZA956419B (en) Pharmaceutical compound
GB9406473D0 (en) Pharmaceutical compound
GB9426091D0 (en) Pharmaceutical compound
GB9514485D0 (en) Pharmaceutical compound
GB9417322D0 (en) Pharmaceutical compounds
GB9417513D0 (en) Pharmaceutical compounds
GB9402806D0 (en) Pharmaceutical compounds
ZA944689B (en) Pharmaceutical compounds
GB9426074D0 (en) Pharmaceutical compounds
GB9426092D0 (en) Pharmaceutical compounds
SG32533A1 (en) Pharmaceutical compounds
GB9417526D0 (en) Pharmaceutical compounds
SG32534A1 (en) Pharmaceutical compounds
GB9402889D0 (en) Pharmaceutical compounds